Systems-based understanding of pharmacological responses with combinations of multidisciplinary methodologies

Biopharmaceutics and Drug Disposition

Volumn 34, Issue 9, 2013, Pages 489-507

  Kariya, Yoshiaki ^a   Honma, Masashi ^a   Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

pharmacological response; simulation; systems biology; systems pharmacology

Indexed keywords

ANALYTIC METHOD; CLINICAL PHARMACOLOGY; COMPUTER PROGRAM; DATA BASE; FEEDBACK SYSTEM; KNOWLEDGE BASE; MATHEMATICS; REVIEW; SYSTEMS BIOLOGY;

DATABASES, FACTUAL; HUMANS; PHARMACOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84890560500     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1865     Document Type: Review

References (95)

1. Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L, Pistello M,. Viral vectors: a look back and ahead on gene transfer technology. New Microbiol 2013; 36: 1-22.
2. Lee LK, Roth CM,. Antisense technology in molecular and cellular bioengineering. Curr Opin Biotechnol 2003; 14: 505-511.
3. International Human Genome Sequencing C. Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931-945. doi: 10.1038/nature03001.
4. Schmutz J, Wheeler J, Grimwood J, et al,. Quality assessment of the human genome sequence. Nature 2004; 429: 365-368. doi: 10.1038/nature02390.
5. Gupta R, Agrawal S, Rao N, Tian Z, Kuang R, Kumar V,. Integrative biomarker discovery for breast cancer metastasis from gene expression and protein interaction data using error-tolerant pattern mining. In BICoB, Al-Mubaid H, (ed). ISCA: Honolulu, Hawaii, 2010; 171-177.
6. Azmi AS, Banerjee S, Ali S, et al,. Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors. Oncotarget 2011; 2: 378-392.
7. Wittenburg LA, Ptitsyn AA, Thamm DH,. A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma. J Cell Biochem 2012; 113: 773-783. doi: 10.1002/jcb.23403.
8. Bensimon A, Heck AJ, Aebersold R,. Mass spectrometry-based proteomics and network biology. Annu Rev Biochem 2012; 81: 379-405. doi: 10.1146/annurev- biochem-072909-100424.
9. Austin CP,. The impact of the completed human genome sequence on the development of novel therapeutics for human disease. Annu Rev Med 2004; 55: 1-13. doi: 10.1146/annurev.med.55.091902.104426.
10. Wheeler DA, Wang L,. From human genome to cancer genome: the first decade. Genome Res 2013; 23: 1054-1062. doi: 10.1101/gr.157602.113.
11. Williams SJ, Hayward NK,. The impact of the Human Genome Project on medical genetics. Trends Mol Med 2001; 7: 229-231.
12. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J,. Cancer: a systems biology disease. Biosystems 2006; 83: 81-90. doi: 10.1016/j.biosystems.2005.05. 014.
13. Caron E, Ghosh S, Matsuoka Y, et al,. A comprehensive map of the mTOR signaling network. Mol Systems Biol 2010; 6: 453. doi: 10.1038/msb.2010.108.
14. Oda K, Matsuoka Y, Funahashi A, Kitano H,. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Systems Biol 2005; 1: 2005 0010. DOI: 10.1038/msb4100014.
15. Mizuno S, Iijima R, Ogishima S, et al,. AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease. BMC Systems Biol 2012; 6: 52. doi: 10.1186/1752-0509-6-52.
16. Friboulet A, Thomas D,. Systems biology-an interdisciplinary approach. Biosensors Bioelectron 2005; 20: 2404-2407. doi: 10.1016/j.bios.2004.11.014.
17. Preusch PC,. Integrative and organ systems pharmacology: a new initiative from the National Institute of General Medical Sciences. Mol Intervent 2004; 4: 72-73. doi: 10.1124/mi.4.2.1.
18. van der Graaf PH, Benson N,. Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development. Pharm Res 2011; 28: 1460-1464. doi: 10.1007/s11095-011-0467-9.
19. van der Graaf PH,. CPT: Pharmacometrics and systems pharmacology. CPT: Pharmacometrics Syst Pharmacol 2012; 1: e8. doi: 10.1038/psp.2012.8.
20. Milligan PA, Brown MJ, Marchant B, et al,. Model-based drug development: a rational approach to efficiently accelerate drug development. Clin Pharmacol Ther 2013; 93: 502-514. doi: 10.1038/clpt.2013.54.
21. Hoffmann R, Valencia A,. A gene network for navigating the literature. Nature Genet 2004; 36: 664. doi: 10.1038/ng0704-664.
22. Ghosh S, Matsuoka Y, Asai Y, Hsin KY, Kitano H,. Software for systems biology: from tools to integrated platforms. Nature Rev Genet 2011; 12: 821-832. doi: 10.1038/nrg3096.
23. UniProt C,. Update on activities at the Universal Protein Resource (UniProt) in 2013. Nucleic Acids Res 2013; 41: D43-D47. doi: 10.1093/nar/gks1068.
24. Kanehisa M, Goto S,. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
25. Harel A, Inger A, Stelzer G, et al,. GIFtS: annotation landscape analysis with GeneCards. BMC Bioinformatics 2009; 10: 348. doi: 10.1186/1471-2105-10- 348.
26. Matthews L, Gopinath G, Gillespie M, et al,. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 2009; 37: D619-D622. doi: 10.1093/nar/gkn863.
27. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M,. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010; 38: D355-D360. doi: 10.1093/nar/gkp896.
28. Thomas PD, Campbell MJ, Kejariwal A, et al,. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003; 13: 2129-2141. doi: 10.1101/gr.772403.
29. Hucka M, Finney A, Sauro HM, et al,. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003; 19: 524-531. doi: 10.1093/bioinformatics/btg015.
30. Schliemann M, Bullinger E, Borchers S, Allgower F, Findeisen R, Scheurich P,. Heterogeneity reduces sensitivity of cell death for TNF-stimuli. BMC Systems Biol 2011; 5: 204. doi: 10.1186/1752-0509-5-204.
31. Koh G, Lee DY,. Mathematical modeling and sensitivity analysis of the integrated TNFalpha-mediated apoptotic pathway for identifying key regulators. Comput Biol Med 2011; 41: 512-528. doi: 10.1016/j.compbiomed.2011.04.017.
32. Helikar T, Kochi N, Kowal B, et al,. A comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cells. PLoS One 2013; 8: e61757. doi: 10.1371/journal.pone.0061757.
33. Garny A, Cooper J, Hunter PJ,. Toward a VPH/physiome tool kit. Wiley Interdiscip Rev Syst Biol Med 2010; 2: 134-147. doi: 10.1002/wsbm.63.
34. Funahashi A, Matsuoka Y, Akiya J, Morohashi M, Kikuchi N, Kitano H,. CellDesigner 3.5: a versatile modeling tool for biochemical networks. Proc IEEE 2008; 96: 1254-1265. doi: 10.1109/JPROC.2008.925458.
35. Oda K, Kitano H,. A comprehensive map of the toll-like receptor signaling network. Mol Systems Biol 2006; 2: 2006 0015. DOI: 10.1038/msb4100057
36. Raber J, Huang Y, Ashford JW,. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25: 641-650. doi: 10.1016/j.neurobiolaging.2003.12.023.
37. Brandes U,. On variants of shortest-path betweenness centrality and their generic computation. Social Networks 2008; 30: 136-145. doi: 10.1016/j.socnet.2007.11.001.
38. Nikolsky Y, Nikolskaya T, Bugrim A,. Biological networks and analysis of experimental data in drug discovery. Drug Discov Today 2005; 10: 653-662. doi: 10.1016/s1359-6446(05)03420-3.
39. Kyoda K, Baba K, Onami S, Kitano H,. DBRF-MEGN method: an algorithm for deducing minimum equivalent gene networks from large-scale gene expression profiles of gene deletion mutants. Bioinformatics 2004; 20: 2662-2675. doi: 10.1093/bioinformatics/bth306.
40. Christiano Silva T, Raphael Amancio D,. Network-based stochastic competitive learning approach to disambiguation in collaborative networks. Chaos 2013; 23: 013139. doi: 10.1063/1.4794795.
41. Cowan NJ, Chastain EJ, Vilhena DA, Freudenberg JS, Bergstrom CT,. Nodal dynamics, not degree distributions, determine the structural controllability of complex networks. PLoS One 2012; 7: e38398. doi: 10.1371/journal.pone.0038398.
42. Szczepanski PL, Michalak T, Rahwan T,. A new approach to betweenness centrality based on the Shapley Value. In Proceedings of the 11th International Conference on Autonomous Agents and Multiagent Systems-Volume 1. International Foundation for Autonomous Agents and Multiagent Systems: Valencia, Spain, 2012; 239-246.
43. Berger SI, Ma'ayan A, Iyengar R,. Systems pharmacology of arrhythmias. Sci Signal 2010; 3: ra30. doi: 10.1126/scisignal.2000723.
44. Matsuki T, Nakae S, Sudo K, Horai R, Iwakura Y,. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int Immunol 2006; 18: 399-407. doi: 10.1093/intimm/dxh379.
45. Borgatti SP, Mehra A, Brass DJ, Labianca G,. Network analysis in the social sciences. Science 2009; 323: 892-895. doi: 10.1126/science.1165821.
46. Fuller MM, Wagner A, Enquist BJ,. Using network analysis to characterize forest structure. Nat Resour Model 2008; 21: 225-247. doi: 10.1111/j.1939-7445. 2008.00004.x.
47. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T,. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011; 27: 431-432. DOI: 10.1093/bioinformatics/btq675
48. Oyama M, Nagashima T, Suzuki T, et al,. Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer. J Biol Chem 2011; 286: 818-829. doi: 10.1074/jbc.M110.156877.
49. Gustafson DL, Siegel D, Rastatter JC, et al,. Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo. J Pharmacol Exp Ther 2003; 305: 1079-1086. doi: 10.1124/jpet.103.050070.
50. Hornberg JJ, Binder B, Bruggeman FJ, Schoeberl B, Heinrich R, Westerhoff HV,. Control of MAPK signalling: from complexity to what really matters. Oncogene 2005; 24: 5533-5542. doi: 10.1038/sj.onc.1208817.
51. Hornberg JJ, Bruggeman FJ, Binder B, et al,. Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control. FEBS J 2005; 272: 244-258. doi: 10.1111/j.1432-1033. 2004.04404.x.
52. Hua F, Cornejo MG, Cardone MH, Stokes CL, Lauffenburger DA,. Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J Immunol 2005; 175: 985-995.
53. Hao H, Zak DE, Sauter T, Schwaber J, Ogunnaike BA,. Modeling the VPAC2-activated cAMP/PKA signaling pathway: from receptor to circadian clock gene induction. Biophys J 2006; 90: 1560-1571. doi: 10.1529/biophysj.105.065250.
54. Vinod PK, Venkatesh KV,. Quantification of the effect of amino acids on an integrated mTOR and insulin signaling pathway. Mol Biosyst 2009; 5: 1163-1173. doi: 10.1039/b816965a.
55. Wanjerkhede SM, Bapi RS,. Role of CAMKII in reinforcement learning: a computational model of glutamate and dopamine signaling pathways. Biol Cybern 2011; 104: 397-424. doi: 10.1007/s00422-011-0439-5.
56. Fujita KA, Toyoshima Y, Uda S, Ozaki Y, Kubota H, Kuroda S,. Decoupling of receptor and downstream signals in the Akt pathway by its low-pass filter characteristics. Sci Signal 2010; 3: ra56. doi: 10.1126/scisignal.2000810.
57. Gu X, Reid D, Higham DJ, Gilbert D,. Mathematical modelling of polyamine metabolism in bloodstream-form Trypanosoma brucei: an application to drug target identification. PLoS One 2013; 8: e53734. doi: 10.1371/journal.pone.0053734.
58. Aoki K, Yamada M, Kunida K, Yasuda S, Matsuda M,. Processive phosphorylation of ERK MAP kinase in mammalian cells. Proc Natl Acad Sci 2011; 108: 12675-12680. doi: 10.1073/pnas.1104030108.
59. Yamamoto N, Honma M, Suzuki H,. Off-target serine/threonine kinase 10 inhibition by erlotinib enhances lymphocytic activity leading to severe skin disorders. Mol Pharmacol 2011; 80: 466-475. doi: 10.1124/mol.110.070862.
60. Helikar T, Rogers JA,. ChemChains: a platform for simulation and analysis of biochemical networks aimed to laboratory scientists. BMC Systems Biol 2009; 3: 58. doi: 10.1186/1752-0509-3-58.
61. Helikar T, Kowal B, McClenathan S, et al,. The Cell Collective: toward an open and collaborative approach to systems biology. BMC Systems Biol 2012; 6: 96. doi: 10.1186/1752-0509-6-96.
62. Liu YY, Slotine JJ, Barabasi AL,. Controllability of complex networks. Nature 2011; 473: 167-173. doi: 10.1038/nature10011.
63. Rangamani P, Sirovich L,. Survival and apoptotic pathways initiated by TNF-alpha: modeling and predictions. Biotechnol Bioeng 2007; 97: 1216-1229. doi: 10.1002/bit.21307.
64. Zhang T, Wu M, Chen Q, Sun Z,. Investigation into the regulation mechanisms of TRAIL apoptosis pathway by mathematical modeling. Acta Biochim Biophys Sin 2010; 42: 98-108. doi: 10.1093/abbs/gmp114.
65. Yan G, Ren J, Lai Y-C, Lai C-H, Li B,. Controlling complex networks: how much energy is needed? Phys Rev Lett 2012; 108. doi: 10.1103/PhysRevLett.108. 218703.
66. Lagonotte P, Sabonnadiere J, Leost J-Y, Paul J-P,. Structural analysis of the electrical system: application to secondary voltage control in France. Power Systems, IEEE Trans 1989; 4: 479-486.
67. Codecasa L, D'Amore D, Maffezzoni P,. Compact modeling of electrical devices for electrothermal analysis. Circuits and Systems I: Fundam Theory Appl, IEEE Trans 2003; 50: 465-476.
68. Colandrea M, de Magistris M, di Bernardo M, Manfredi S,. A fully reconfigurable experimental setup to study complex networks of Chua's circuits. In Nonlinear Dynamics of Electronic Systems, Proceedings of NDES 2012. VDE: Wolfenbüttel, 2012; 1-4.
69. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ,. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29: 235-271.
70. de Visser KE, Eichten A, Coussens LM,. Paradoxical roles of the immune system during cancer development. Nature Rev Cancer 2006; 6: 24-37.
71. van der Wulp MY, Verkade HJ, Groen AK,. Regulation of cholesterol homeostasis. Mol Cell Endocrinol 2013; 368: 1-16. doi: 10.1016/j.mce.2012.06. 007.
72. Haraguchi R, Ashihara T, Namba T, et al,. Transmural dispersion of repolarization determines scroll wave behavior during ventricular tachyarrhythmias. Circ J: official journal of the Japanese Circulation Society 2011; 75: 80-88.
73. Friedrich O, Both M, Weber C, et al,. Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle. Biophys J 2010; 98: 606-616.
74. Reynolds A, Bard Ermentrout G, Clermont G,. A mathematical model of pulmonary gas exchange under inflammatory stress. J Theor Biol 2010; 264: 161-173. doi: 10.1016/j.jtbi.2010.01.011.
75. Waters M, Stasiewicz S, Merrick BA, et al,. CEBS-chemical effects in biological systems: a public data repository integrating study design and toxicity data with microarray and proteomics data. Nucleic Acids Res 2008; 36: D892-D900. doi: 10.1093/nar/gkm755.
76. Davis AP, Murphy CG, Johnson R, et al,. The comparative toxicogenomics database: update 2013. Nucleic Acids Res 2013; 41: D1104-D1114. doi: 10.1093/nar/gks994.
77. Obayashi T, Okamura Y, Ito S, Tadaka S, Motoike IN, Kinoshita K,. COXPRESdb: a database of comparative gene coexpression networks of eleven species for mammals. Nucleic Acids Res 2013; 41: D1014-D1020. doi: 10.1093/nar/gks1014.
78. Knox C, Law V, Jewison T, et al,. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011; 39: D1035-D1041. doi: 10.1093/nar/gkq1126.
79. Parkinson H, Kapushesky M, Kolesnikov N, et al,. ArrayExpress update-from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 2009; 37: D868-D872. doi: 10.1093/nar/gkn889.
80. International HapMap C, Altshuler DM, Gibbs RA, Peltonen L, et al,. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52-58. doi: 10.1038/nature09298.
81. Hunter S, Jones P, Mitchell A, et al,. InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res 2012; 40: D306-D312. doi: 10.1093/nar/gkr948.
82. Heinz DW, Baase WA, Dahlquist FW, Matthews BW,. How amino-acid insertions are allowed in an alpha-helix of T4 lysozyme. Nature 1993; 361: 561-564. doi: 10.1038/361561a0.
83. Ashburner M, Ball CA, Blake JA, et al,. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29. doi: 10.1038/75556.
84. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P,. A side effect resource to capture phenotypic effects of drugs. Mol Systems Biol 2010; 6: 343. doi: 10.1038/msb.2009.98.
85. Collins FS, Gray GM, Bucher JR,. Toxicology. Transforming environmental health protection. Science 2008; 319: 906-907. doi: 10.1126/science.1154619.
86. Chelliah V, Laibe C, Le Novere N,. BioModels database: a repository of mathematical models of biological processes. Methods Mol Biol 2013; 1021: 189-199. doi: 10.1007/978-1-62703-450-0-10.
87. Olivier BG, Snoep JL,. Web-based kinetic modelling using JWS Online. Bioinformatics 2004; 20: 2143-2144. doi: 10.1093/bioinformatics/bth200.
88. Wittig U, Kania R, Golebiewski M, et al,. SABIO-RK-database for biochemical reaction kinetics. Nucleic Acids Res 2012; 40: D790-D796. doi: 10.1093/nar/gkr1046.
89. Sanford C, Yip ML, White C, Parkinson J,. Cell++-simulating biochemical pathways. Bioinformatics 2006; 22: 2918-2925. doi: 10.1093/bioinformatics/ btl497.
90. Hoops S, Sahle S, Gauges R, et al,. COPASI-a COmplex PAthway SImulator. Bioinformatics 2006; 22: 3067-3074. doi: 10.1093/bioinformatics/btl485.
91. Westergaard M, Kristensen L,. The Access/CPN Framework: a tool for interacting with the CPN tools simulator. In Applications and Theory of Petri Nets, Franceschinis G, Wolf K, (eds). Springer: Berlin Heidelberg, 2009; 313-322.
92. Baigent S,. Software review. Gepasi 3.0. Brief Bioinform 2001; 2: 300-302.
93. Hattne J, Fange D, Elf J,. Stochastic reaction-diffusion simulation with MesoRD. Bioinformatics 2005; 21: 2923-2924. doi: 10.1093/bioinformatics/bti431.
94. Wishart DS, Yang R, Arndt D, Tang P, Cruz J,. Dynamic cellular automata: an alternative approach to cellular simulation. In Silico Biol 2005; 5: 139-161.
95. Cowan AE, Moraru II, Schaff JC, Slepchenko BM, Loew LM,. Spatial modeling of cell signaling networks. Methods Cell Biol 2012; 110: 195-221. doi: 10.1016/B978-0-12-388403-9.00008-4.